204 related articles for article (PubMed ID: 23788305)
21. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.
Stanciu AE; Vatasescu RG; Stanciu MM; Iorgulescu C; Vasile AI; Dorobantu M
Clin Biochem; 2013 Feb; 46(3):230-4. PubMed ID: 23159290
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
[TBL] [Abstract][Full Text] [Related]
23. Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy.
Szulik M; Stabryła-Deska J; Boidol J; Lenarczyk R; Kalarus Z; Kukulski T
Kardiol Pol; 2011; 69(10):1043-51. PubMed ID: 22006606
[TBL] [Abstract][Full Text] [Related]
24. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
[TBL] [Abstract][Full Text] [Related]
25. Antiarrhythmic effect of cardiac resynchronization therapy with triple-site biventricular stimulation.
Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Mizuno K
Europace; 2013 Oct; 15(10):1491-8. PubMed ID: 23696627
[TBL] [Abstract][Full Text] [Related]
26. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
[TBL] [Abstract][Full Text] [Related]
27. Whether noninvasive optimization of AV and VV delays improves the response to cardiac resynchronization therapy.
Urbanek B; Chudzik M; Klimczak A; Rosiak M; Lewek J; Wranicz JK
Cardiol J; 2013; 20(4):411-7. PubMed ID: 23913460
[TBL] [Abstract][Full Text] [Related]
28. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
29. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
30. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
[TBL] [Abstract][Full Text] [Related]
31. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
[TBL] [Abstract][Full Text] [Related]
32. Acute improvement of left ventricular relaxation as a predictor of volume reduction after cardiac resynchronization therapy: a pilot study assessing the value of left ventricular hemodynamic parameter.
Kato H; Shimano M; Sumi T; Murakami H; Kada K; Inden Y; Tsuboi N; Murohara T
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1544-52. PubMed ID: 25113752
[TBL] [Abstract][Full Text] [Related]
33. Utility of echocardiographic tissue synchronization imaging to redirect left ventricular epicardial lead placement for cardiac resynchronization therapy.
Zhang Y; Li ZA; He YH; Zhang HB; Meng X
Chin Med J (Engl); 2013 Nov; 126(22):4222-6. PubMed ID: 24238501
[TBL] [Abstract][Full Text] [Related]
34. The arterial baroreflex effectiveness index in risk stratification of chronic heart failure patients who are candidates for cardiac resynchronization therapy.
Fernandes Serôdio J; Martins Oliveira M; Matoso Laranjo S; Tavares C; Silva Cunha P; Abreu A; Branco L; Alves S; Rocha I; Cruz Ferreira R
Rev Port Cardiol; 2016 Jun; 35(6):343-50. PubMed ID: 27255174
[TBL] [Abstract][Full Text] [Related]
35. Long-term clinical response to cardiac resynchronisation therapy under a multidisciplinary model.
O'Donnell D; Lin T; Swale M; Rae P; Flannery D; Srivastava PM
Intern Med J; 2013 Nov; 43(11):1216-23. PubMed ID: 24015775
[TBL] [Abstract][Full Text] [Related]
36. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
37. Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients.
Seifert M; Schlegl M; Hoersch W; Fleck E; Doelger A; Stockburger M; Butter C
Int J Cardiol; 2007 Sep; 121(1):68-73. PubMed ID: 17582527
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
39. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
40. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
